These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 18848798)
1. Pyomyositis caused by extended-spectrum beta-lactamase-producing Escherichia coli in a patient with acute myeloid leukemia. Chiu SK; Chang FY Int J Infect Dis; 2009 May; 13(3):e85-7. PubMed ID: 18848798 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome. Cordery RJ; Roberts CH; Cooper SJ; Bellinghan G; Shetty N J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198 [TBL] [Abstract][Full Text] [Related]
4. Infections due to Escherichia coli producing extended-spectrum beta-lactamase among hospitalised patients: factors influencing mortality. Peña C; Gudiol C; Calatayud L; Tubau F; Domínguez MA; Pujol M; Ariza J; Gudiol F J Hosp Infect; 2008 Feb; 68(2):116-22. PubMed ID: 18226420 [TBL] [Abstract][Full Text] [Related]
5. Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy. Ozden E; Bostanci Y; Yakupoglu KY; Akdeniz E; Yilmaz AF; Tulek N; Sarikaya S Urology; 2009 Jul; 74(1):119-23. PubMed ID: 19464043 [TBL] [Abstract][Full Text] [Related]
6. Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome. Ortega M; Marco F; Soriano A; Almela M; Martínez JA; Muñoz A; Mensa J J Antimicrob Chemother; 2009 Mar; 63(3):568-74. PubMed ID: 19126669 [TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes and therapeutic options of bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Metan G; Zarakolu P; Cakir B; Hascelik G; Uzun O Int J Antimicrob Agents; 2005 Sep; 26(3):254-7. PubMed ID: 16122910 [TBL] [Abstract][Full Text] [Related]
8. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. Trecarichi EM; Tumbarello M; Spanu T; Caira M; Fianchi L; Chiusolo P; Fadda G; Leone G; Cauda R; Pagano L J Infect; 2009 Apr; 58(4):299-307. PubMed ID: 19272650 [TBL] [Abstract][Full Text] [Related]
9. Ertapenem in the treatment of bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli: a propensity score analysis. Wu UI; Chen WC; Yang CS; Wang JL; Hu FC; Chang SC; Chen YC Int J Infect Dis; 2012 Jan; 16(1):e47-52. PubMed ID: 22055248 [TBL] [Abstract][Full Text] [Related]
10. Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital. Koksal F; Ak K; Kucukbasmaci O; Samasti M Chemotherapy; 2009; 55(4):293-7. PubMed ID: 19521075 [TBL] [Abstract][Full Text] [Related]
11. Escherichia coli Pyomyositis: an emerging infectious disease among patients with hematologic malignancies. Vigil KJ; Johnson JR; Johnston BD; Kontoyiannis DP; Mulanovich VE; Raad II; Dupont HL; Adachi JA Clin Infect Dis; 2010 Feb; 50(3):374-80. PubMed ID: 20038242 [TBL] [Abstract][Full Text] [Related]
12. [Clinical study of the urinary tract infections due to Escherichia coli harboring extended-spectrum beta lactamase]. Hori J; Yamaguchi S; Osanai H; Kinebuchi T; Usami K; Takahashi N; Ishii Y Hinyokika Kiyo; 2007 Nov; 53(11):777-82. PubMed ID: 18051801 [TBL] [Abstract][Full Text] [Related]
13. Escherichia coli pyomyositis in an immunocompromised host. Sharma U; Schwan WR; Agger WA WMJ; 2011 Aug; 110(4):182-4. PubMed ID: 22413629 [TBL] [Abstract][Full Text] [Related]
14. The impact of diagnostic delay on the course of septic shock caused by extended-spectrum-beta- lactamase-producing Escherichia coli. Gashi M; Raka L; Ahmeti S; Gashi S; Dika A; Gashi G Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):846-7. PubMed ID: 19736487 [No Abstract] [Full Text] [Related]
15. Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bacteremia. Risk factors and outcome in the eastern region of Saudi Arabia. Memon JI; Rehmani RS; Ahmed MU; Elgendy AM; Nizami IY Saudi Med J; 2009 Jun; 30(6):803-8. PubMed ID: 19526164 [TBL] [Abstract][Full Text] [Related]
16. Septicemia, meningitis, and skull osteomyelitis complicating infected cephalhematoma caused by ESBL-producing Escherichia coli. Nakwan N; Nakwan N; Wannaro J; Dissaneevate P; Kritsaneepaiboon S; Chokephaibulkit K Southeast Asian J Trop Med Public Health; 2011 Jan; 42(1):148-51. PubMed ID: 21323177 [TBL] [Abstract][Full Text] [Related]
17. A prospective study of ceftriaxone treatment in acute pyelonephritis caused by extended-spectrum beta-lactamase-producing bacteria. Suankratay C; Jutivorakool K; Jirajariyavej S J Med Assoc Thai; 2008 Aug; 91(8):1172-81. PubMed ID: 18788687 [TBL] [Abstract][Full Text] [Related]
18. Successful treatment of ctx-m ESBL producing Escherichia coli relapsing pyelonephritis with long term pivmecillinam. Nicolle LE; Mulvey MR Scand J Infect Dis; 2007; 39(8):748-9. PubMed ID: 17654359 [TBL] [Abstract][Full Text] [Related]
19. [Antibiotic resistance rates of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella spp. strains isolated from urinary tract infections in a private hospital]. Akyar I Mikrobiyol Bul; 2008 Oct; 42(4):713-5. PubMed ID: 19149097 [TBL] [Abstract][Full Text] [Related]
20. Successful treatment of multidrug-resistant Escherichia coli bacteremia with tigecycline in an acute myeloid leukemia child. Ozdemir H; Ciftçi E; Karbuz A; Oktay G; Aysev D; Yavuz G; Ince E Turk J Pediatr; 2012; 54(1):59-60. PubMed ID: 22397044 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]